ras oncogenes in human cancer: a review - PubMed
- ️Sun Jan 01 1989
Review
. 1989 Sep 1;49(17):4682-9.
Affiliations
- PMID: 2547513
Review
ras oncogenes in human cancer: a review
J L Bos. Cancer Res. 1989.
Erratum in
- Cancer Res 1990 Feb 15;50(4):1352
Abstract
Mutations in codon 12, 13, or 61 of one of the three ras genes, H-ras, K-ras, and N-ras, convert these genes into active oncogenes. Rapid assays for the detection of these point mutations have been developed recently and used to investigate the role mutated ras genes play in the pathogenesis of human tumors. It appeared that ras gene mutations can be found in a variety of tumor types, although the incidence varies greatly. The highest incidences are found in adenocarcinomas of the pancreas (90%), the colon (50%), and the lung (30%); in thyroid tumors (50%); and in myeloid leukemia (30%). For some tumor types a relationship may exist between the presence of a ras mutation and clinical or histopathological features of the tumor. There is some evidence that environmental agents may be involved in the induction of the mutations.
Similar articles
-
Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J, Horáková I, Novotná H, Opáalka P, Roubková H. Vachtenheim J, et al. Clin Cancer Res. 1995 Mar;1(3):359-65. Clin Cancer Res. 1995. PMID: 9815992
-
The ras gene family in human non-small-cell lung cancer.
Slebos RJ, Rodenhuis S. Slebos RJ, et al. J Natl Cancer Inst Monogr. 1992;(13):23-9. J Natl Cancer Inst Monogr. 1992. PMID: 1327034
-
Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Rosell R, Li S, Skacel Z, Mate JL, Maestre J, Canela M, Tolosa E, Armengol P, Barnadas A, Ariza A. Rosell R, et al. Oncogene. 1993 Sep;8(9):2407-12. Oncogene. 1993. PMID: 8395679
-
Occurrence of ras mutations in human lung cancer. Minireview.
Vachtenheim J. Vachtenheim J. Neoplasma. 1997;44(3):145-9. Neoplasma. 1997. PMID: 9372854 Review.
-
Rodenhuis S. Rodenhuis S. Semin Cancer Biol. 1992 Aug;3(4):241-7. Semin Cancer Biol. 1992. PMID: 1421168 Review.
Cited by
-
Influence of DNA repair on nonlinear dose-responses for mutation.
Thomas AD, Jenkins GJ, Kaina B, Bodger OG, Tomaszowski KH, Lewis PD, Doak SH, Johnson GE. Thomas AD, et al. Toxicol Sci. 2013 Mar;132(1):87-95. doi: 10.1093/toxsci/kfs341. Epub 2013 Jan 3. Toxicol Sci. 2013. PMID: 23288051 Free PMC article.
-
Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.
Ochocki JD, Distefano MD. Ochocki JD, et al. Medchemcomm. 2013 Mar;4(3):476-492. doi: 10.1039/C2MD20299A. Medchemcomm. 2013. PMID: 25530833 Free PMC article.
-
Liao CF, Lin SH, Chen HC, Tai CJ, Chang CC, Li LT, Yeh CM, Yeh KT, Chen YC, Hsu TH, Shen SC, Lee WR, Chiou JF, Luo SF, Jiang MC. Liao CF, et al. Mol Med. 2012 Dec 6;18(1):1269-80. doi: 10.2119/molmed.2012.00205. Mol Med. 2012. PMID: 22952058 Free PMC article.
-
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.
Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, Sougnez C, Stewart C, Sivachenko A, Wang L, Wan Y, Zhang W, Shukla SA, Vartanov A, Fernandes SM, Saksena G, Cibulskis K, Tesar B, Gabriel S, Hacohen N, Meyerson M, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ. Landau DA, et al. Cell. 2013 Feb 14;152(4):714-26. doi: 10.1016/j.cell.2013.01.019. Cell. 2013. PMID: 23415222 Free PMC article.
-
Kim J, Parrish AB, Kurokawa M, Matsuura K, Freel CD, Andersen JL, Johnson CE, Kornbluth S. Kim J, et al. EMBO J. 2012 Mar 7;31(5):1279-92. doi: 10.1038/emboj.2011.491. Epub 2012 Jan 13. EMBO J. 2012. PMID: 22246185 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous